Gapping up
In reaction to strong earnings/guidance: CMTL +6.4%, DIOD +4.7%, ABM +4.5%, TOL +3.6%, LL +1.2%, BURL +0.5%, (light volume), HITK +0.2%, (light volume).
M&A related: VTNC +6.1% (Vitran to be acquired by Manitoulin Transport for $6.00 per share), TI +4.5% (Telecom Italia not considering breakup of TIM Participacoes, according to reports ), TBOW (Trunkbow enters into merger agreement for 'going private' transaction for $1.46/share).
Select Brazil related names showing strength: CIG +9.8%, GFA +4.7%, PBR +1.3%.
Select metals/mining stocks trading higher: AG +2%, GDX +1.8%, NEM +1.7%, AU +1.7%, GFI +1.7%, GG +1.6%, SLV +1.5%, AUY +1.3%, ABX +1.2%, GOLD +0.2%.
Other news: GERN +16.8% (Geron seeing some volatility in after hours trading; co presented data on imetelstat at ASH and is scheduled to host an analyst and investor meeting; upgraded to Buy at Needham), NAVB +14.8% (FDA grants fast track designation to Navidea Biopharmaceuticals' Lymphoseek for sentinel lymph node detection in patients with head and neck cancer ), SYN +12% (Synthetic Biologics and Intrexon (XON) initiate Development of Novel Biologics for a Subset of Patients Suffering from Irritable Bowel Syndrome ), RMBS +7.9%/ MU +0.3% (Rambus and Micron sign license agreement), DRWI +7.8% (continued strength), NURO +6.7% (to partner with Omron Medical Devices for Distribution of NC-stat DPNCheck in China), CTIC +4.4% (presents interim results from Phase 2 Tosedostat Trial in older patients with acute myeloid leukemia or myelodysplastic syndrome), HL +4.2% (still checking), PLUG +4.2% (continued strength), LULU +2.9% (appoints Laurent Potdevin as CEO), ARWR +2.7% (presents Phase 1 Data on ARC-520 at HepDART 2013 -- New data including pharmacokinetics (PK) and adverse event (AE) attribution presented today in a poster and in an oral presentation tomorrow, support the previous findings that ARC-520 appears to be generally safe and well-tolerated at all six dose levels studied), ACI +2.6% (has begun operating its longwall mining system), IRM +2.5% (discloses it entered into a REIT Status Protection Rights Agreement), STM +2.3% (still checking), EVTC +2% (announces commencement of public offering of 15,287,473 shares of its common stock by selling stockholders and concurrent repurchase of its common stock), SODA +1.3% (following late spike), MED +1% (announces it has completed repurchase 786k shares of common stock under 1.125 mln share authorization at average price of $25.46), HON +0.7% (announces Major Investments to Increase HFO-1234yf Production in the United States), PXD +0.5% (still checking), BA +0.5% (WSJ discusses Boeing's (BA) tactics to lower its taxes), GM +0.4% (Treasury sold its remaining stake), TWC +0.4% (Time Warner Cable and Charter (CHTR) execs are in no rush for deals, according to reports), YHOO +0.3% (to give more details on revenue composition, according to reports), NAT +0.3% (issues latter to shareholders; says 'Bright spots on the horizon are the strong tendencies we see in global ton-mile demand '), ENDP +0.2% (receives FDA 510(k) clearance of the RetroArc Retropubic Sling System for treatment of female stress urinary incontinence), KO +0.2% (plans to introduce low calorie Coke, according to reports )
Analyst comments: HAWK +9.8% (upgraded to Buy from Neutral at Citigroup), RLYP +5.6% (initiated with an Overweight at Morgan Stanley, initiated with a Outperform at Wedbush), ARIA +4.9% (upgraded to Buy from Hold at Stifel), NVMI +1.4% (initiated with a Buy at Canaccord), DDD +1.3% (initiated with a Buy at Deutsche Bank), OSIS +1.1% (Sell-off is overdone; risk of debarment is low -- The Benchmark Company ), SSYS +1% (initiated with a Buy at Deutsche Bank), JCI +1% (upgraded to Top Pick at RBC Capital Mkts; tgt $61), RDS.A +0.6% (upgraded to Neutral from Underweight at JP Morgan), PKI +0.5% (upgraded to Outperform from Neutral at Macquarie ), URI +0.4% (upgraded to Top Pick at RBC Capital Mkts), HAR +0.1% (upgraded to Outperform from Market Perform at Wells Fargo).
M&A related: VTNC +6.1% (Vitran to be acquired by Manitoulin Transport for $6.00 per share), TI +4.5% (Telecom Italia not considering breakup of TIM Participacoes, according to reports ), TBOW (Trunkbow enters into merger agreement for 'going private' transaction for $1.46/share).
Select Brazil related names showing strength: CIG +9.8%, GFA +4.7%, PBR +1.3%.
Select metals/mining stocks trading higher: AG +2%, GDX +1.8%, NEM +1.7%, AU +1.7%, GFI +1.7%, GG +1.6%, SLV +1.5%, AUY +1.3%, ABX +1.2%, GOLD +0.2%.
Other news: GERN +16.8% (Geron seeing some volatility in after hours trading; co presented data on imetelstat at ASH and is scheduled to host an analyst and investor meeting; upgraded to Buy at Needham), NAVB +14.8% (FDA grants fast track designation to Navidea Biopharmaceuticals' Lymphoseek for sentinel lymph node detection in patients with head and neck cancer ), SYN +12% (Synthetic Biologics and Intrexon (XON) initiate Development of Novel Biologics for a Subset of Patients Suffering from Irritable Bowel Syndrome ), RMBS +7.9%/ MU +0.3% (Rambus and Micron sign license agreement), DRWI +7.8% (continued strength), NURO +6.7% (to partner with Omron Medical Devices for Distribution of NC-stat DPNCheck in China), CTIC +4.4% (presents interim results from Phase 2 Tosedostat Trial in older patients with acute myeloid leukemia or myelodysplastic syndrome), HL +4.2% (still checking), PLUG +4.2% (continued strength), LULU +2.9% (appoints Laurent Potdevin as CEO), ARWR +2.7% (presents Phase 1 Data on ARC-520 at HepDART 2013 -- New data including pharmacokinetics (PK) and adverse event (AE) attribution presented today in a poster and in an oral presentation tomorrow, support the previous findings that ARC-520 appears to be generally safe and well-tolerated at all six dose levels studied), ACI +2.6% (has begun operating its longwall mining system), IRM +2.5% (discloses it entered into a REIT Status Protection Rights Agreement), STM +2.3% (still checking), EVTC +2% (announces commencement of public offering of 15,287,473 shares of its common stock by selling stockholders and concurrent repurchase of its common stock), SODA +1.3% (following late spike), MED +1% (announces it has completed repurchase 786k shares of common stock under 1.125 mln share authorization at average price of $25.46), HON +0.7% (announces Major Investments to Increase HFO-1234yf Production in the United States), PXD +0.5% (still checking), BA +0.5% (WSJ discusses Boeing's (BA) tactics to lower its taxes), GM +0.4% (Treasury sold its remaining stake), TWC +0.4% (Time Warner Cable and Charter (CHTR) execs are in no rush for deals, according to reports), YHOO +0.3% (to give more details on revenue composition, according to reports), NAT +0.3% (issues latter to shareholders; says 'Bright spots on the horizon are the strong tendencies we see in global ton-mile demand '), ENDP +0.2% (receives FDA 510(k) clearance of the RetroArc Retropubic Sling System for treatment of female stress urinary incontinence), KO +0.2% (plans to introduce low calorie Coke, according to reports )
Analyst comments: HAWK +9.8% (upgraded to Buy from Neutral at Citigroup), RLYP +5.6% (initiated with an Overweight at Morgan Stanley, initiated with a Outperform at Wedbush), ARIA +4.9% (upgraded to Buy from Hold at Stifel), NVMI +1.4% (initiated with a Buy at Canaccord), DDD +1.3% (initiated with a Buy at Deutsche Bank), OSIS +1.1% (Sell-off is overdone; risk of debarment is low -- The Benchmark Company ), SSYS +1% (initiated with a Buy at Deutsche Bank), JCI +1% (upgraded to Top Pick at RBC Capital Mkts; tgt $61), RDS.A +0.6% (upgraded to Neutral from Underweight at JP Morgan), PKI +0.5% (upgraded to Outperform from Neutral at Macquarie ), URI +0.4% (upgraded to Top Pick at RBC Capital Mkts), HAR +0.1% (upgraded to Outperform from Market Perform at Wells Fargo).